Login / Signup

Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer.

Ian M McElreeRyan L SteinbergAlex C MartinJordan RichardsSarah L MottPaul T GellhausKenneth G NeppleMichael A O'DonnellVignesh T Packiam
Published in: The Journal of urology (2022)
Gem/Doce is an effective and well-tolerated therapy for BCG-naïve NMIBC. Further investigation is warranted.
Keyphrases
  • muscle invasive bladder cancer
  • locally advanced
  • radiation therapy
  • bacillus subtilis
  • urinary tract